Cantel Medical Reports Financial Results for the Third Quarter Ended April 30, 2017
Cantel Medical reported GAAP net income of $17,511,000, or $0.42 per diluted share, on a 10.6% increase in sales to $192,113,000 for the third quarter ended April 30, 2017. This compares with net income of $14,019,000, or $0.34 per diluted share, on sales of $173,703,000 for the third quarter ended April 30, 2016.
Cantel Medical Completes Acquisition of Select Endoscopy Assets from CR Kennedy
Cantel Medical announced today the completion of its acquisition of endoscopy business assets from Australian distributor, CR Kennedy & Company Pty. Ltd.
President and CEO Jorgen B. Hansen Rings NYSE opening bell
Company celebrates 20th year of leadership in infection prevention.
CANTEL Acquires Endoscopy Assets from Vantage Endoscopy
The Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.